Jeremy Sugarman

About

Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, a professor of medicine, and a professor of Health Policy and Management at Johns Hopkins University. He serves as the deputy director for medicine of the Berman Institute of Bioethics at Johns Hopkins. He is an internationally recognized leader in bioethics with particular expertise in applying empirical methods and evidence-based standards for evaluating and analyzing bioethical issues. His contributions include work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, global health, and research oversight. Dr. Sugarman has authored over 400 articles, reviews, and book chapters, and has edited or co-edited four books on bioethics topics. He has served on various advisory boards and committees, including the White House Advisory Committee on Human Radiation Experiments, the National Bioethics Advisory Commission, and the Presidential Commission for the Study of Bioethical Issues. His research interests encompass informed consent, stem cell research, global health, emerging technologies, research oversight, and clinical trial design. He has held academic positions at Duke University and is a faculty affiliate of the Kennedy Institute of Ethics at Georgetown University. Dr. Sugarman is a member of several prestigious organizations, including the National Academy of Medicine, the American Society of Clinical…

Research topics

• Political Science
• Sociology
• Medicine
• Psychology
• Law
• Biology
• Virology
• Immunology
• Engineering ethics
• Pathology

Selected publications

• Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

  New England Journal of Medicine · 2021 · 832 citations

  BACKGROUND: Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. METHODS: We conducted a randomized, double-blind, double-dummy, noninferiority trial to compare long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) at a dose of 600 mg, given intramuscularly every 8 weeks, with daily oral tenofovir disoproxil fumara…

  PublisherOA PDFDOI

• Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

  Nature Medicine · 2021 · 359 citations

  DOI

• ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

  Stem Cell Reports · 2021 · 343 citations

  The International Society for Stem Cell Research has updated its Guidelines for Stem Cell Research and Clinical Translation in order to address advances in stem cell science and other relevant fields, together with the associated ethical, social, and policy issues that have arisen since the last update in 2016. While growing to encompass the evolving science, clinical applications of stem cells, and the increasingly complex implications of stem cell research for society, the basic principles und…

  PublisherOA PDFDOI

• Experimental Philosophical Bioethics

  AJOB Empirical Bioethics · 2020 · 55 citations

  There is a rich tradition in bioethics of gathering empirical data to inform, supplement, or test the implications of normative ethical analysis. To this end, bioethicists have drawn on diverse methods, including qualitative interviews, focus groups, ethnographic studies, and opinion surveys to advance understanding of key issues in bioethics. In so doing, they have developed strong ties with neighboring disciplines such as anthropology, history, law, and sociology. Collectively, these lines of…

  DOI

• Addressing Ethical Challenges in US-Based HIV Phylogenetic Research

  The Journal of Infectious Diseases · 2020 · 54 citations

  In recent years, phylogenetic analysis of HIV sequence data has been used in research studies to investigate transmission patterns between individuals and groups, including analysis of data from HIV prevention clinical trials, in molecular epidemiology, and in public health surveillance programs. Phylogenetic analysis can provide valuable information to inform HIV prevention efforts, but it also has risks, including stigma and marginalization of groups, or potential identification of HIV transmi…

  DOI

Recent grants

• NIH Grant R21MH092253

  NIH · $448k · 2014

• NIH Grant R56AI100695

  NIH · $620k · 2016

• NIH Grant R01HL075538

  NIH · $2.9M · 2009

Frequent coauthors

• Ruth Faden

  Johns Hopkins University

  156 shared

• Kevin P. Weinfurt

  Duke University

  154 shared

• Jeffrey Kahn

  150 shared

• Benjamin S. Wilfond

  University of Washington

  116 shared

• Lisa Eckenwiler

  106 shared

• Christine Grady

  National Institutes of Health Clinical Center

  105 shared

• Dale E. Hammerschmidt

  University of Minnesota Medical Center

  104 shared

• Carol Levine

  United Hospital Fund

  104 shared

Awards & honors

• Doctor of Science, honoris causa, from New York Medical Coll…

Similar researchers at Johns Hopkins University

• Mary Catherine Beachh-87
• Thomas H. Gallagherh-57